|
|
Office Locations:
|
135 Beaver Street, Suite 400
Waltham, MA 02452
Phone: 781-237-6910
Fax: 781-237-6911
| | |
|
|
|
|
|
Life Sciences & Healthcare
Medical Device
|
|
|
|
Founded in 1998, MedEquity Capital, LLC is a private equity firm investing in mid- to late-stage healthcare service and product companies. MEI has invested over $110 million, typically seeking investments in the range of $5 million to $30 million, and pursues investments in provider-based services, Specialty Pharmacy, outsourcing, distribution, product companies with low technology risk, and technology-enabled services. Uses of capital include buyout, organic growth, acquisition strategies or consolidation plays, and recapitalizations (full or partial liquidity). The firm targets companies with revenues of $5 million or greater and EBITDA range of $1 million to $10 million.
|
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
